EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Identification of novel drug targets for multiple sclerosis by integrating plasma genetics and proteomes

Yi Liu, Qian Wang, Yuhui Zhao, Liu Liu, Jingxi Hu, Yao Qiao, Jinyi Chen, Chao Qin

Experimental Gerontology · 2024

DOI: 10.1016/j.exger.2024.112505 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Gerontology, 2024. Verfasst von Yi Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, First Affiliated Hospital of Guangxi Medical University, Nanning, China; Department of Neurology, Shanxi Provincial People's…. Hauptthemen laut MEDLINE: Multiple Sclerosis, Genome-Wide Association Study, Proteome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shanxi Provincial Key Research and Development Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Genome-wide association studies (GWAS) have revealed numerous loci associated with multiple sclerosis (MS). However, the challenge lies in deciphering the mechanisms by which these loci influence the target traits. Here, we employed an integrative analytical pipeline to efficiently transform genetic associations to identify novel proteins for MS. METHODS: We systematically integrated MS GWAS data (N = 115,803) with human plasma proteome data (N = 7213) and conducted proteome-wide association studies (PWAS) to identify MS-associated pathogenic proteins. Following this, we employed Mendelian randomization and Bayesian colocalization analyses to verify the causal relationship between these significant plasma proteins and MS. Lastly, we utilized the Drug-Gene Interaction Database (DGIdb) to identify potential drug targets for MS. RESULTS: The PWAS identified 25 statistically significant cis-regulated plasma proteins associated with MS at a false discovery rate of P < 0.05. Further analysis revealed that the abundance of 7 of these proteins (PLEK, TNXB, CASP3, CD59, CR1, TAPBPL, ATXN3) was causally related to the incidence of MS. Our findings indicated that genetically predicted higher levels of TNXB and CD59 were associated with a lower risk of MS, whereas higher levels of PLEK, CASP3, CR1, TAPBPL, and ATXN3 were associated with an increased risk of MS. Three plasma proteins (PLEK, CR1, CD59) were validated by colocalization analysis. Among these, CR1 was prioritized as a target for Eculizumab due to its significant association with MS risk. Additionally, PLEK, CR1, and CD59 were identified as druggable target genes. CONCLUSIONS: Our proteomic analysis has identified PLEK, CR1, and CD59 as potential drug targets for MS treatment. Developing pharmacological inducers or inhibitors for these proteins could pave the way for new therapeutic approaches, potentially improving outcomes for MS patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisGenome-Wide Association StudyProteomeHumansBayes TheoremBlood ProteinsMendelian Randomization AnalysisCD59 AntigensGenetic Predisposition to DiseaseProteomics

Stichwörter der Autor:innen

Bayesian colocalizationGenome-wide association studiesMendelian randomizationMultiple sclerosisProteome-wide association studies

Substanzen

ProteomeBlood ProteinsCD59 AntigensCD59 protein, human

Autor:innen und Institutionen

  • Department of Neurology, First Affiliated Hospital of Guangxi Medical University, Nanning, China; Department of Neurology, Shanxi Provincial People's Hospital, The Fifth Clinical Medical College of Shanxi Medical Univer…
  • Department of Neurology, Shanxi Provincial People's Hospital, The Fifth Clinical Medical College of Shanxi Medical University, Taiyuan, China; Shanxi Medical University, Taiyuan, China.
  • Department of Neurology, First Affiliated Hospital of Guangxi Medical University, Nanning, China. Electronic address: chaoqin620@aliyun.com.

Förderung

  • Shanxi Provincial Key Research and Development Project

Zitieren

APA

Liu, Y., Wang, Q., Zhao, Y., Liu, L., Hu, J., Qiao, Y., Chen, J., & Qin, C. (2024). Identification of novel drug targets for multiple sclerosis by integrating plasma genetics and proteomes. Experimental Gerontology. https://doi.org/10.1016/j.exger.2024.112505

Vancouver

Liu Y, Wang Q, Zhao Y, Liu L, Hu J, Qiao Y, et al. Identification of novel drug targets for multiple sclerosis by integrating plasma genetics and proteomes. Experimental Gerontology. 2024. doi:10.1016/j.exger.2024.112505

BibTeX
@article{Liu2024,
  author = {Liu, Yi and Wang, Qian and Zhao, Yuhui and Liu, Liu and Hu, Jingxi and Qiao, Yao and Chen, Jinyi and Qin, Chao},
  title = {Identification of novel drug targets for multiple sclerosis by integrating plasma genetics and proteomes},
  journal = {Experimental Gerontology},
  year = {2024},
  doi = {10.1016/j.exger.2024.112505}
}
Kostenlos starten →